COVID-19与帕金森病嗅觉障碍的代谢相关脑区不重叠
研究对44例SARS-CoV2感染后嗅觉减退患者行脑[18F]-FDG PET,并与82例未用药帕金森病伴嗅觉减退患者比较。COVID-嗅觉减退组较无嗅觉减退组双侧直回和眶额皮质代谢减低,且与帕金森病组代谢相关脑区不重叠。
要点
- COVID-19后持续性嗅觉减退表现为双侧直回和眶额皮质代谢减低。
- COVID-19后嗅觉减退与帕金森病嗅觉减退的脑代谢相关区域不重叠。
- 嗅觉测试评分与脑代谢的相关区域在两组间不同。
核心结论
- COVID-19后持续性嗅觉减退的代谢特征涉及嗅觉感知相关皮层区域,与帕金森病嗅觉减退的代谢相关脑区不重叠。
研究设计与样本
- 44例SARS-CoV2感染后出现嗅觉减退的患者在康复后6个月内接受脑[18F]-FDG PET,采用16项「Sniffin' Sticks」测试评估嗅觉并分为COVID-嗅觉减退组和COVID-无嗅觉减退组。
- COVID-嗅觉减退组(n=21)与COVID-无嗅觉减退组(n=23)在SPM12中比较,并与82例未用药帕金森病伴嗅觉减退患者比较。
- 采用多元回归分析识别患者亚组中嗅觉测试评分与脑代谢的相关性。
主要发现
- COVID-嗅觉减退组(n=21)较COVID-无嗅觉减退组(n=23)双侧直回和眶额皮质代谢显著减低(p<0.002)。
- COVID-嗅觉减退组较帕金森病嗅觉减退组中颞回和上颞回、内侧/中额回及右侧岛叶代谢显著减低(p<0.012)。
- 帕金森病嗅觉减退组较COVID-嗅觉减退组双侧枕下/中回和楔叶代谢减低。
- COVID-嗅觉减退组嗅觉测试评分与双侧直回和内侧额回及右侧中颞回和前扣带回代谢直接相关(p<0.006)。
- 帕金森病嗅觉减退组嗅觉测试评分与双侧楔叶/楔前叶和左侧外侧枕叶皮层代谢相关(p<0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hyposmia is a common feature of COVID-19 and Parkinson's disease (PD). As parkinsonism has been reported after COVID-19, a link has been hypothesized between SARS-CoV2 infection and PD. We aimed to evaluate brain metabolic correlates of isolated persistent hyposmia after mild-to-moderate COVID-19 and to compare them with metabolic signature of hyposmia in drug-naïve PD patients. METHODS: Forty-four patients who experienced hyposmia after SARS-COV2 infection underwent brain [18F]-FDG PET in the first 6 months after recovery. Olfaction was assessed by means of the 16-item "Sniffin' Sticks" test and patients were classified as with or without persistent hyposmia (COVID-hyposmia and COVID-no-hyposmia respectively). Brain [18F]-FDG PET of post-COVID subgroups were compared in SPM12. COVID-hyposmia patients were also compared with eighty-two drug-naïve PD patients with hyposmia. Multiple regression analysis was used to identify correlations between olfactory test scores and brain metabolism in patients' subgroups. RESULTS: COVID-hyposmia patients (n = 21) exhibited significant hypometabolism in the bilateral gyrus rectus and orbitofrontal cortex with respect to COVID-non-hyposmia (n = 23) (p < 0.002) and in middle and superior temporal gyri, medial/middle frontal gyri, and right insula with respect to PD-hyposmia (p < 0.012). With respect to COVID-hyposmia, PD-hyposmia patients showed hypometabolism in inferior/middle occipital gyri and cuneus bilaterally. Olfactory test scores were directly correlated with metabolism in bilateral rectus and medial frontal gyri and in the right middle temporal and anterior cingulate gyri in COVID-hyposmia patients (p < 0.006) and with bilateral cuneus/precuneus and left lateral occipital cortex in PD-hyposmia patients (p < 0.004). CONCLUSION: Metabolic signature of persistent hyposmia after COVID-19 encompasses cortical regions involved in olfactory perception and does not overlap metabolic correlates of hyposmia in PD.
引用
- Morbelli S, Chiola S, Donegani MI, et al. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap. Eur J Nucl Med Mol Imaging. 2022. PMID: 34984501. doi:10.1007/s00259-021-05666-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。